Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claudia Berger is active.

Publication


Featured researches published by Claudia Berger.


Biochemical and Biophysical Research Communications | 2003

Novel human G-protein coupled receptor

Jakob Venema; Claudia Berger; Christiane Löken; Willy Deleersnijder; Guy Nys

Human G-protein coupled receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein coupled receptor polypeptides, respectively. Also disclosed are diagnostic methods for detecting a mutation in the G-protein coupled receptor nucleic acid sequences and an altered level of the soluble form of the receptors.


British Journal of Pharmacology | 2003

Identification and functional characterization of hemorphins VV-H-7 and LVV-H-7 as low-affinity agonists for the orphan bombesin receptor subtype 3.

Hans-Peter Lammerich; Annette Busmann; Christian Kutzleb; Martin Wendland; Petra Seiler; Claudia Berger; Peter Eickelmann; Markus Meyer; Wolf-Georg Forssmann; Erik Maronde

The human orphan G‐protein coupled receptor bombesin receptor subtype 3 (hBRS‐3) was screened for peptide ligands by a Ca2+ mobilization assay resulting in the purification and identification of two specific ligands, the naturally occurring VV‐hemorphin‐7 (VV‐H‐7) and LVV‐hemorphin‐7 (LVV‐H‐7), from human placental tissue. These peptides were functionally characterized as full agonists with unique specificity albeit low affinity for hBRS‐3 compared to other bombesin receptors. VV‐H‐7 and LVV‐H‐7 induced a dose‐dependent response in hBRS‐3 overexpressing CHO cells, as well as in NCI‐N417 cells expressing the hBRS‐3 endogenously. The affinity of VV‐H‐7 was higher in NCI‐N417 cells compared to overexpressing CHO cells. In detail, the EC50 values were 45±15 μM for VV‐H‐7 and 183±60 μM for LVV‐H‐7 in CHO cells, and 19±6 μM for VV‐H‐7 and 38±18 μM for LVV‐H‐7 in NCI‐N417 cells. Other hemorphins had no effect. Gastrin‐releasing peptide (GRP) and neuromedin B (NMB) showed similar EC50 values of 13–20 μM (GRP) and of 1–2 μM (NMB) on both cell lines. Structure‐function analysis revealed that both the N‐terminal valine and the C‐terminal phenylalanine residues of VV‐H‐7 are critical for the ligand‐receptor interaction. Endogenous hBRS‐3 in NCI‐N417 activated by VV‐H‐7 couples to phospholipase C resulting in changes of intracellular calcium, which is initially released from an inositol trisphosphate (IP3)‐sensitive store followed by a capacitive calcium entry from extracellular space. VV‐H‐7‐induced hBRS‐3 activation led to phosphorylation of p42/p44‐MAP kinase in NCI‐N417 cells, but did not stimulate cell proliferation. In contrast, phosphorylation of focal adhesion kinase (p125FAK) was not observed.


Journal of Medicinal Chemistry | 2003

Design of selective peptidomimetic agonists for the human orphan receptor BRS-3

Dirk Weber; Claudia Berger; Peter Eickelmann; Jochen Antel; Horst Kessler


Journal of Peptide Science | 2002

Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3

Dirk Weber; Claudia Berger; Timo Heinrich; Peter Eickelmann; Jochen Antel; Horst Kessler


Archive | 2004

Non-peptidic BRS-3 agonists

Dirk Weber; Horst Kessler; Claudia Berger; Jochen Antel; Timo Heinrich


Archive | 2002

Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments

Claudia Berger; Yvan Fischer; Dagmar Höltje; Harald Waldeck; Michael Weske; Dieter Ziegler


Archive | 2003

Compounds with NEP/MP-inhibitory activity and uses thereof

Claudia Berger; Yvan Fischer; Dagmar Hoeltje; Harald Waldeck; Michael Weske; Dieter Ziegler


Archive | 2004

Antibodies immunospecific for a novel human G-protein coupled receptor family

Jakob Venema; Claudia Berger; Christiane Löken; Willy Deleersnijder; Guy Nys


Archive | 2005

Binding assay employing IGS4, a human G-protein coupled neuromedin receptor

Jakob Venema; Claudia Berger; Christiane Löken; Willy Deleersnijder; Guy Nys


Archive | 2005

Polynucleotides and expression system of a novel human G-protein coupled receptor

Jakob Venema; Claudia Berger; Christiane Löken; Willy Deleersnijder; Guy Nys

Collaboration


Dive into the Claudia Berger's collaboration.

Researchain Logo
Decentralizing Knowledge